Załeska, Monika <br/><br/>
[Elevated serum NSE level in locally advanced and metastatic NSCLC predispose to better response to chemotherapy but worse survival].  [electronic resource] 

 -  Pneumonologia i alergologia polska  2010 
 - 14-20 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0867-7077 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Neoplasm--blood<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--blood<br/>Carcinoembryonic Antigen--blood<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chorionic Gonadotropin, beta Subunit, Human--blood<br/>Female<br/>Ferritins--blood<br/>Humans<br/>Keratin-19--blood<br/>L-Lactate Dehydrogenase--blood<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Phosphopyruvate Hydratase--blood<br/>Prognosis<br/>Severity of Illness Index<br/>Survival Analysis<br/>Survival Rate